NASDAQ : BJDX
Bluejay Diagnostics, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 0.5403 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.41M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.49M |
| Enterprise Value | -7.03M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 4.47M |
| Shares Outstanding | 4.47M |
| Shares Change (YoY) | +558.09% |
| Shares Change (QoQ) | +111.16% |
| Owned by Insiders (%) | 2.03% |
| Owned by Institutions (%) | 8.76% |
| Float | 4.38M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.12 |
| P/TBV Ratio | 0.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.64 |
| Quick Ratio | 4.53 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8,737.06 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -98.89% |
| Return on Assets (ROA) | -51.08% |
| Return on Invested Capital (ROIC) | -61.24% |
| Return on Capital Employed (ROCE) | -77.84% |
| Weighted Average Cost of Capital (WACC) | 8.89% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.21M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.89 |
| 52-Week Price Change | -93.93% |
| 50-Day Moving Average | 0.82 |
| 200-Day Moving Average | 1.85 |
| Relative Strength Index (RSI) | 28.50 |
| Average Volume (20 Days) | 457,287 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 144,402 |
| Short Previous Month | 143,737 |
| Short % of Shares Out | 3.23% |
| Short % of Float | 3.30% |
| Short Ratio (days to cover) | 0.20 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.33M |
| Pretax Income | -7.27M |
| Net Income | -7.27M |
| EBITDA | -7.24M |
| EBIT | -7.33M |
| Earnings Per Share (EPS) | -$6.65 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 9.60M |
| Total Debt | 80,670 |
| Net Cash | 9.52M |
| Net Cash Per Share | $2.13 |
| Equity (Book Value) | 9.41M |
| Book Value Per Share | 4.75 |
| Working Capital | 7.70M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -5.90M |
| Capital Expenditures | -335,497 |
| Depreciation & Amortization | 93,995 |
| Net Borrowing | -4,169 |
| Free Cash Flow | -6.24M |
| FCF Per Share | -$1.40 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -558.09% |
| Shareholder Yield | -558.09% |
| Earnings Yield | -1,194.76% |
| FCF Yield | -250.95% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jan 29, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |